Stock 002728 TEYI PHARMACEUTICAL GROUP CO.,LTD
Add to a list
To use this feature you must be a member
Log inSign up

Company Teyi Pharmaceutical Group Co.,Ltd

Equities

002728

CNE100001WK6

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 29/04/2024 BST 		5-day change 1st Jan Change
9.61 CNY +0.73% Intraday chart for Teyi Pharmaceutical Group Co.,Ltd -7.02% -24.92%
04-19 Teyi Pharmaceutical Group Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
03-07 Teyi Pharmaceutical Group Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

TEYI PHARMACEUTICAL GROUP CO., LTD, formerly Guangdong Taicheng Pharmaceutical Co., Ltd., is principally engaged in the production and sale of pharmaceuticals. The Company primarily provides Chinese traditional patent medicines, including cough arresting and phlegm removing medicine series, kidney reinforcing medicine series and anti-infection medicine series, among others. The Company's products mainly include tablets, granules, medicinal tea, syrup, decocted extracts, capsules, powder, ointment, cream, as well as oral solutions, among others.

Number of employees: 1,243

Sales per Business

CNY in Million2022Weight2023Weight Delta
Chinese Patent Medicine
54.6 %
404 45.6 % 582 54.6 % +44.06%
Chemical Preparation
39.1 %
409 46.1 % 417 39.1 % +2.05%
Chemical Raw Materials
5.8 %
68 7.6 % 62 5.8 % -8.08%
Chemical Products and Others
0.5 %
6 0.7 % 6 0.5 % -6.26%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
886 99.9 % 1,067 100.0 % +20.46%
International
0.0 %
1 0.1 % 0 0.0 % -65.43%

Managers

Managers TitleAgeSince
Dan Qing Xu CEO
 Chief Executive Officer 55 14/06/09
Xi Liang Chen DFI
 Director of Finance/CFO 52 14/06/09
Wei Cheng Wu BRD
 Director/Board Member 55 26/11/18
Song Qing Xu BRD
 Director/Board Member 54 14/06/09
Shao Hua Xu IRC
 Investor Relations Contact - -

Members of the board

Members of the board TitleAgeSince
Dan Qing Xu CEO
 Chief Executive Officer 55 14/06/09
Song Qing Xu BRD
 Director/Board Member 54 14/06/09
Xi Liang Chen DFI
 Director of Finance/CFO 52 14/06/09
Gui Sheng Li BRD
 Director/Board Member 51 26/11/18
Xiao Bing Huang BRD
 Director/Board Member 52 14/05/12
Beijing Lu BRD
 Director/Board Member 41 31/10/15
Yan Ming Cao BRD
 Director/Board Member 52 26/11/18
Ming Jian Zhang CHM
 Chairman 41 30/06/08
Wei Cheng Wu BRD
 Director/Board Member 55 26/11/18
Jia Jun Shen BRD
 Director/Board Member 31 26/06/22

Shareholders

NameEquities%Valuation
Zhong Ou Asset Management Co., Ltd
0.8664 %
1,938,800 0.8664 % 4 M ¥
Hui'an Fund Management Co. Ltd.
0.0794 %
177,740 0.0794 % 390 281 ¥
Everbright Securities Asset Management Co., Ltd.
0.0226 %
50,540 0.0226 % 110 976 ¥
China Asset Management Co., Ltd.
0.0199 %
44,620 0.0199 % 97 977 ¥
Sealand Securities Co., Ltd. (Investment Management)
0.009897 %
22,148 0.009897 % 48 633 ¥
BOC International China Ltd. (Investment Management)
0.009009 %
20,160 0.009009 % 44 267 ¥
AVIC Fund Management Co. Ltd.
0.004826 %
10,800 0.004826 % 23 715 ¥
China Fund Management Co., Ltd.
0.004665 %
10,440 0.004665 % 22 924 ¥
Broad Fund Management Co. Ltd.
0.004397 %
9,840 0.004397 % 21 607 ¥
CICC Fund Management Ltd.
0.001323 %
2,960 0.001323 % 6 500 ¥

Company contact information

Teyi Pharmaceutical Group Co., Ltd.

9 & 11 Changxing Road Taicheng

529200, Taishan

+86 75 0562 7588

http://www.tczy.com.cn
address Teyi Pharmaceutical Group Co.,Ltd(002728)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
9.61
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
TEYI PHARMACEUTICAL GROUP CO.,LTD Stock Teyi Pharmaceutical Group Co.,Ltd
-24.92% 678M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+33.25% 699B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+28.89% 571B
JOHNSON & JOHNSON Stock Johnson & Johnson
-3.55% 364B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.16% 326B
ABBVIE INC. Stock AbbVie Inc.
+4.36% 286B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.96% 236B
NOVARTIS AG Stock Novartis AG
+4.96% 198B
ROCHE HOLDING AG Stock Roche Holding AG
-10.80% 194B
AMGEN INC. Stock Amgen Inc.
-3.69% 149B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 002728 Stock
  4. Company Teyi Pharmaceutical Group Co.,Ltd